glp-1 obesity drug news Only one in 12 remain on a for at three years The GLP-1 Access Gap: Mapping
Description
[DOI] [Google Scholar] 239.Slingu M
In one 2024 study, high levels of glucose and triglycerides and low levels of high-density lipoproteinwhich are usually signs of worse metabolic healthwere associated with future risk of depression and anxiety ( JAMA Network Open , DOI: 10.1001/jamanetworkopen.2024.4525)
Tresiba has no effect on appetite or eating behavior
10.1016/j.neuron.2009.04.017 [DOI] [PMC free article] [PubMed] [Google Scholar] de Miranda A
